(Q44115593)

29 November 2017

title

MPP(+) and glutamate in the degeneration of nigral dopaminergic neurons (English)

1 reference

29 November 2017

Sawada H

1

1 reference

29 November 2017

Shimohama S

series ordinal

2

1 reference

29 November 2017

publication date

1 December 1999

1 reference

29 November 2017

number of pages

7

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

29 November 2017

volume

5

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

209-215

1 reference

An endogenous dopaminergic neurotoxin: implication for Parkinson's disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Mutant debrisoquine hydroxylation genes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Point mutations of mitochondrial genome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Oxygen free radicals and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

An introduction to the free radical hypothesis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Glutamate as a CNS transmitter. II. Regulation of synthesis in the releasable pool

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx into rat brain cortex cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Glutamate neurotoxicity in cortical cell culture is calcium dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Oxidative stress induced by glutamate receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Seven-year follow-up study of bromocriptine therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Distribution of D2 dopamine receptor mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2899%2900039-5

7 January 2021

10.1016/S1353-8020(99)00039-5

Identifiers

DOI

1 reference

29 November 2017

1 reference